BioTime Announces the Formation of Embryome Sciences, Inc. for the Development and Commercialization of Stem Cell Technology

Published: Dec 12, 2007

EMERYVILLE, Calif.--(BUSINESS WIRE)--BioTime, Inc. (OTCBB:BTIM) today announced that it has organized a new subsidiary, Embryome Sciences, Inc. The mission of the new company is to participate in the emerging field of regenerative medicine known as “embryomics”.

Back to news